Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-22T19:33:13.679Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of aripiprazole for psychosis and agitation in dementia

Published online by Cambridge University Press:  28 October 2005

Jerson Laks ,
Roberto Miotto ,
Valeska Marinho  and
Eliasz Engelhardt
Jerson Laks
Affiliation:
Center for Alzheimer's Disease and Related Disorders, Institute of Psychiatry, Federal University of Rio de Janeiro, RJ, Brazil
Roberto Miotto
Affiliation:
Integrated Unit of Mental Health, Navy of Brazil, Brazil
Valeska Marinho
Affiliation:
Center for Alzheimer's Disease and Related Disorders, Institute of Psychiatry, Federal University of Rio de Janeiro, RJ, Brazil
Eliasz Engelhardt
Affiliation:
Section of Cognitive and Behavioral Neurology, Institute of Neurology, Federal University of Rio de Janeiro, RJ, Brazil
Get access

Abstract

We report the case of an elderly woman with Alzheimer's disease, risk factors for vascular dementia, and atrium-ventricular blockade, who presented with severe agitation and psychosis. She was treated with aripiprazole and assessed with the Neuropsychiatric Inventory (NPI) over the course of 14 weeks. NPI scores showed a marked decrease in psychosis and agitation at week 4, and complete recovery at week 14, except for depression.

Type
Case Reports
Information
International Psychogeriatrics , Volume 18 , Issue 2 , June 2006 , pp. 335 - 340
Copyright
International Psychogeriatric Association 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)